Literature DB >> 16434423

Government-NGO collaboration: the case of tuberculosis control in Bangladesh.

A N Zafar Ullah1, James N Newell, Jalal Uddin Ahmed, M K A Hyder, Akramul Islam.   

Abstract

This study analyzes the basic concepts and key issues of existing collaboration between government and non-governmental organizations (NGOs) in health care, using as an example the implementation of the DOTS (formerly an abbreviation for directly observed treatment, short course) strategy for tuberculosis (TB) control in Bangladesh. It also examines efforts by the Government of Bangladesh to improve health services delivery, especially for the poor, through collaboration with NGOs. Data were collected in 2001 and 2002 as a part of the process of developing a public-private partnership model for TB care in Bangladesh. Analyses of existing collaboration models in TB control strongly suggest that the government and NGO sectors can be complementary in controlling TB. We found an increasing trend of government collaborating with NGOs in implementing TB control programmes. The study indicates that government-NGO collaboration is an effective way of improving access to and quality of TB and other health care services.

Entities:  

Mesh:

Year:  2006        PMID: 16434423     DOI: 10.1093/heapol/czj014

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  10 in total

1.  Socio-demographic factors affecting knowledge level of Tuberculosis patients in Rajshahi City, Bangladesh.

Authors:  M N I Mondal; Hoque M Nazrul; M R K Chowdhury; J Howard
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Achieving universal health coverage through community empowerment: a proposition for bangladesh.

Authors:  Taufique Joarder; Malabika Sarker
Journal:  Indian J Community Med       Date:  2014-07

3.  Where do the poorest go to seek outpatient care in Bangladesh: hospitals run by government or microfinance institutions?

Authors:  Yu-hwei Tseng; Mujibul Alam Khan
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

4.  Bibliometric analysis of worldwide publications on multi-, extensively, and totally drug - resistant tuberculosis (2006-2015).

Authors:  Waleed M Sweileh; Adham S AbuTaha; Ansam F Sawalha; Suleiman Al-Khalil; Samah W Al-Jabi; Sa'ed H Zyoud
Journal:  Multidiscip Respir Med       Date:  2017-01-11

5.  Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh.

Authors:  Sayera Banu; Farhana Haque; Shahriar Ahmed; Sonia Sultana; Md Mahfuzur Rahman; Razia Khatun; Kishor Kumar Paul; Senjuti Kabir; S M Mazidur Rahman; Rupali Sisir Banu; Md Shamiul Islam; Allen G Ross; John D Clemens; Robert Stevens; Jacob Creswell
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

6.  Public-private partnerships in primary health care: a scoping review.

Authors:  Nasrin Joudyian; Leila Doshmangir; Mahdi Mahdavi; Jafar Sadegh Tabrizi; Vladimir Sergeevich Gordeev
Journal:  BMC Health Serv Res       Date:  2021-01-04       Impact factor: 2.655

7.  Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries.

Authors:  Anant Bhan; Jerome A Singh; Ross E G Upshur; Peter A Singer; Abdallah S Daar
Journal:  PLoS Med       Date:  2007-09       Impact factor: 11.069

8.  Towards a midwifery profession in Bangladesh--a systems approach for a complex world.

Authors:  Malin Upper Bogren; Helena Wigert; Lars Edgren; Marie Berg
Journal:  BMC Pregnancy Childbirth       Date:  2015-12-03       Impact factor: 3.007

9.  Health system delay in treatment of multidrug resistant tuberculosis patients in Bangladesh.

Authors:  Mahfuza Rifat; John Hall; Christopher Oldmeadow; Ashaque Husain; Abul Hasnat Milton
Journal:  BMC Infect Dis       Date:  2015-11-16       Impact factor: 3.090

10.  Public-non-governmental organisation partnerships for health: an exploratory study with case studies from recent Ghanaian experience.

Authors:  Martin Hushie
Journal:  BMC Public Health       Date:  2016-09-13       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.